24/08/2026
The End of the Opioid-or-Nothing Choice? A New Era of Non-Addictive Pain Relief
For decades, treating severe pain has often meant balancing powerful relief against the risk of dependence and addiction. Now, a new approach is changing the conversation.
Suzetrigine (Journavx) represents a different strategy: targeting pain signaling more selectively rather than relying on the same pathways used by opioids.
This documentary explores the science behind the drug, why its mechanism matters, the challenges of replacing opioids, and what wider adoption could mean for the future of pain management.
A potential new chapter in medicine — where effective pain relief doesn't have to come with the same addiction pathway.